A pilot study to assess the immunologic and virologic efficacy of generic nevirapine, zidovudine and lamivudine in the treatment of HIV-1 infected women with pre-exposure to single dose nevirapine or short course zidovudine and their spouses in Chitungwiza, Zimbabwe.

The Central African journal of medicine

Volumn 52, Issue 1-2, 2006, Pages 1-8

  Zijenah, L S ^a   Kadzirange, G ^a   Rusakaniko, S ^a   Kufa, T ^a   Gonah, N ^a   Tobaiwa, O ^a   Gwanzura, C ^a   Matsikire, E ^a   Katzenstein, D A ^a  

^a UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GENERIC DRUG; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CHI SQUARE DISTRIBUTION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NONPARAMETRIC TEST; PILOT STUDY; SPOUSE; TREATMENT OUTCOME; ZIMBABWE;

ADULT; ANALYSIS OF VARIANCE; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHI-SQUARE DISTRIBUTION; DRUGS, GENERIC; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LAMIVUDINE; MALE; NEVIRAPINE; PILOT PROJECTS; SPOUSES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; ZIDOVUDINE; ZIMBABWE;

EID: 35348886099     PISSN: 00089176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)